| Page 1255 | Kisaco Research
 

Xiaoyong Liu

Director, AI Platform
Alibaba

Xiaoyong Liu

Director, AI Platform
Alibaba

Xiaoyong Liu

Director, AI Platform
Alibaba
 

Robert Crousore

Managing Partner
Health Frontier Ventures

Robert has 28 years of experience in the health care products and
services industry. Crousore is a serial entrepreneur with multiple
successful product and services company exits. His experience spans
the entire business enterprise including Sales, Marketing, Operations,
Product Innovation and, most recently M & A.

Highlights Include:

Robert Crousore

Managing Partner
Health Frontier Ventures

Robert Crousore

Managing Partner
Health Frontier Ventures

Robert has 28 years of experience in the health care products and
services industry. Crousore is a serial entrepreneur with multiple
successful product and services company exits. His experience spans
the entire business enterprise including Sales, Marketing, Operations,
Product Innovation and, most recently M & A.

Highlights Include:

  • Has successfully managed a global commercial organization in the wound care business.
  • Has a number of patent credits for products in the wound care industry.
  • Sits on multiple boards of healthcare technology companies.
  • His passion is creating meaningful changes in patient care by combining great products with great teams  that are focused on empowering improved clinical and financial outcomes.

 

 

Thomas Busby

Vice President
Outcome Capital

Thomas Busby is a Vice President  and has been with Outcome Capital since 2015.  He focuses on medical technology, digital health and life science services segments with particular interest in innovative life science companies that deliver patient impact by leveraging novel approaches.  Thomas is driven by the desire to identify disruptive technologies and services that require unique strategic thought and assistance to realize their full market potential.

Thomas Busby

Vice President
Outcome Capital

Thomas Busby

Vice President
Outcome Capital

Thomas Busby is a Vice President  and has been with Outcome Capital since 2015.  He focuses on medical technology, digital health and life science services segments with particular interest in innovative life science companies that deliver patient impact by leveraging novel approaches.  Thomas is driven by the desire to identify disruptive technologies and services that require unique strategic thought and assistance to realize their full market potential. Thomas has been published in leading life science journals Life Science Leader and The Pharma Letter, and also serves on the board of HealthTech Build, a Boston-based digital health innovation group.

 

Prior to his career in life-science investment banking, Thomas pursued his passion for the public service and non-profit sectors working in a variety of leadership and management positions, and at one time held a Massachusetts teaching license.

Thomas completed his MBA at Suffolk University’s Sawyer Business School on full academic scholarship where he was President of the school’s Graduate Business Association and class speaker at graduation. Prior, he completed a BS in Philosophy with Honors from Suffolk’s College of Arts & Sciences. Committed to giving back, Thomas is currently the President of the College of Arts & Sciences Alumni Board of Directors. Thomas is a FINRA Registered Securities Representative holding his Series 79 and 63.

 

Brannon Morisoli

Director
SWK Holdings

Mr. Morisoli joined SWK Holdings as a Senior Analyst in March 2016. Prior to joining SWK, he was an Investment Analyst and Portfolio Manager for a family office that invested in equities, fixed income, real estate, and alternative investments. Prior to that, he was an Investment Analyst for Presidium Group, a real estate private equity firm, where he played an integral role in closing over $100mm in transactions. Mr.

Brannon Morisoli

Director
SWK Holdings

Brannon Morisoli

Director
SWK Holdings

Mr. Morisoli joined SWK Holdings as a Senior Analyst in March 2016. Prior to joining SWK, he was an Investment Analyst and Portfolio Manager for a family office that invested in equities, fixed income, real estate, and alternative investments. Prior to that, he was an Investment Analyst for Presidium Group, a real estate private equity firm, where he played an integral role in closing over $100mm in transactions. Mr. Morisoli began his career at Neurografix, a startup medical technology company in Santa Monica, CA that was doing groundbreaking work in the MRI imaging of peripheral nerves. While with Neurografix, he was published in two leading neurology journals. Brannon graduated from UCLA with a B.S., was awarded a fellowship and graduated from the University of Notre Dame with an M.B.A, and was awarded a Samson Fellowship from the University of Wisconsin Law School, where he graduated with a J.D. Mr. Morisoli is an inactive member of the State Bar of Wisconsin

 

Sakyasingha Dasgupta

Founder & CEO
EdgeCortix

Sakya is the founder and Chief Executive officer of EdgeCortix. He is an artificial intelligence (AI) and machine learning technologist, entrepreneur, and engineer with over a decade of experience in taking cutting edge AI research from ideation stage to scalable products, across different industry verticals.  He has lead teams at global companies like Microsoft and IBM Research / IBM Japan, along with national research labs like RIKEN Japan and the Max Planck Institute Germany.

Sakyasingha Dasgupta

Founder & CEO
EdgeCortix

Sakyasingha Dasgupta

Founder & CEO
EdgeCortix

Sakya is the founder and Chief Executive officer of EdgeCortix. He is an artificial intelligence (AI) and machine learning technologist, entrepreneur, and engineer with over a decade of experience in taking cutting edge AI research from ideation stage to scalable products, across different industry verticals.  He has lead teams at global companies like Microsoft and IBM Research / IBM Japan, along with national research labs like RIKEN Japan and the Max Planck Institute Germany. Previously, he helped establish and lead the technology division at lean startups in Japan and Singapore, in semiconductor technology, robotics and Fintech sectors. Sakya is the inventor of over 20 patents and has published widely on machine learning and AI with over 1,000 citations. 

Sakya holds a PhD. in Physics of Complex Systems from the Max Planck Institute in Germany, along with Masters in Artificial Intelligence from The University of Edinburgh and a Bachelors of Computer Engineering. Prior to founding EdgeCortix he completed his entrepreneurship studies from the MIT Sloan School of Management.

 

Harshit Khaitan

Director, AI Accelerators
Meta

Harshit Khaitan is the Director of AI Accelerator at Meta where he leads building AI Accelerators for Reality labs products. Prior to Meta, he was technical lead and co-founder for the Edge Machine learning accelerators at Google, responsible for MLA in Google Pixel 4 (Neural Core) and Pixel 6 (Google Tensor SoC). He has also held individual and technical leadership positions at Google’s first Cloud TPU, Nvidia Tegra SoCs and Nvidia GPUs. He has 10+ US and international patents in On-device AI acceleration.

Harshit Khaitan

Director, AI Accelerators
Meta

Harshit Khaitan

Director, AI Accelerators
Meta

Harshit Khaitan is the Director of AI Accelerator at Meta where he leads building AI Accelerators for Reality labs products. Prior to Meta, he was technical lead and co-founder for the Edge Machine learning accelerators at Google, responsible for MLA in Google Pixel 4 (Neural Core) and Pixel 6 (Google Tensor SoC). He has also held individual and technical leadership positions at Google’s first Cloud TPU, Nvidia Tegra SoCs and Nvidia GPUs. He has 10+ US and international patents in On-device AI acceleration. He has a Master’s degree in Computer Engineering from North Carolina State University and a Bachelor’s degree in Electrical Engineering from Manipal Institute of Technology, India.

 

Divya Jain

Director of Adobe Sensei platform
Adobe

Divya Jain is an industry recognized product and technology leader in machine learning and AI. She has 15+ years of industry experience at various startups and Fortune 500 companies. She is currently serving as an Engineering Director for Sensei ML platform at Adobe. Before this she was a Research Director at Tyco Innovation Garage and led various deep learning initiatives in video surveillance space. She also co-founded a startup, dLoop Inc., which was acquired by Box in 2013. At Box, Divya led the team that built the first machine learning capabilities into the Box platform.

Divya Jain

Director of Adobe Sensei platform
Adobe

Divya Jain

Director of Adobe Sensei platform
Adobe

Divya Jain is an industry recognized product and technology leader in machine learning and AI. She has 15+ years of industry experience at various startups and Fortune 500 companies. She is currently serving as an Engineering Director for Sensei ML platform at Adobe. Before this she was a Research Director at Tyco Innovation Garage and led various deep learning initiatives in video surveillance space. She also co-founded a startup, dLoop Inc., which was acquired by Box in 2013. At Box, Divya led the team that built the first machine learning capabilities into the Box platform. She is very passionate about open sharing of knowledge and information and always working towards abridging technology gap for product innovation.

 

Will Singleterry

Commercial Director - Immuno-Oncology
LUMICKS

Will Singleterry

Commercial Director - Immuno-Oncology
LUMICKS

Will Singleterry

Commercial Director - Immuno-Oncology
LUMICKS
 

Melissa Sebok

Executive Director – Product, Client & Business Development, Direct Patient Care & Emerging Offerings
American Red Cross

Melissa Sebok

Executive Director – Product, Client & Business Development, Direct Patient Care & Emerging Offerings
American Red Cross

Melissa Sebok

Executive Director – Product, Client & Business Development, Direct Patient Care & Emerging Offerings
American Red Cross
 

Christina Bailey

Director, Cell and Gene Therapy, NanoString Technologies
Nanostring

Christina Bailey

Director, Cell and Gene Therapy, NanoString Technologies
Nanostring

Christina Bailey

Director, Cell and Gene Therapy, NanoString Technologies
Nanostring